SMARTag™ ADC Technology
Summary:SMARTag™ ADC technology enables biologic innovators to develop more efficacious antibody drug conjugates faster. Developed by Redwood Bioscience, this platform leverages Catalent’s biologic drug development expertise, advanced GPEx® expression system, clinical biomanufacturing and integrated services, offering a number of advantages to ADC developers.